The Pill's gestation: from birth control to cancer prevention

Maguire, 2011, The state of hormonal contraception today: established and emerging noncontraceptive health benefits, Am J Obstet Gynecol, 205, S4, 10.1016/j.ajog.2011.06.056

Beral, 2008, Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87 303 controls, Lancet, 371, 303, 10.1016/S0140-6736(08)60167-1

Havrilesky, 2013, Oral contraceptive use for the primary prevention of ovarian cancer, Evid Rep Technol Assess, 212, 1

Vessey, 1968, Investigation of relation between use of oral contraceptives and thromboembolic disease, BMJ, 2, 199, 10.1136/bmj.2.5599.199

Brinton, 1995, Oral contraceptives and breast cancer risk among younger women, J Natl Cancer Inst, 87, 827, 10.1093/jnci/87.11.827

Kiley, 2007, Combined oral contraceptives: a comprehensive review, Clin Obstet Gynecol, 50, 868, 10.1097/GRF.0b013e318159c06a

2015, Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies, Lancet Oncol

Pike, 2000, Hormonal contraception and chemoprevention of female cancers, Endocr Relat Cancer, 7, 73, 10.1677/erc.0.0070073

Lu, 2013, Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome, Cancer Prev Res, 6, 774, 10.1158/1940-6207.CAPR-13-0020

Walker, 2015, Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer, Cancer, 10.1002/cncr.29321